Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label Phase 1 Study to Evaluate the Safety and Efficacy of AB-1015 in Patients With Resistant/Refractory Epithelial Ovarian Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05617755
Title field or adapter rule
{'original_value': 'An Open-label Phase 1 Study to Evaluate the Safety and Efficacy of AB-1015 in Patients With Resistant/Refractory Epithelial Ovarian Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:29.909478+00:00
Published At
2026-10-29T00:00:00+00:00
Record Updated At
2026-10-29
Source Retrieved At
2026-10-31T22:18:15.087634+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Carcinoma, Ovarian Epithelial", "Ovarian Neoplasms", "Fallopian Tube Neoplasms", "Peritoneal Neoplasms", "Neoplasms, Glandular and Epithelial", "Ovarian Diseases", "Genital Neoplasm, Female", "Abdominal Neoplasm", "Recurrence"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-29", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT05617755"
protocolSection.identificationModule.officialTitle
"An Open-label Phase 1 Study to Evaluate the Safety and Efficacy of AB-1015 in Patients With Resistant/Refractory Epithelial Ovarian Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Carcinoma, Ovarian Epithelial (protocolSection.conditionsModule.conditions)
  • Ovarian Neoplasms (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Neoplasms (protocolSection.conditionsModule.conditions)
  • Peritoneal Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasms, Glandular and Epithelial (protocolSection.conditionsModule.conditions)
  • Ovarian Diseases (protocolSection.conditionsModule.conditions)
  • Genital Neoplasm, Female (protocolSection.conditionsModule.conditions)
  • Abdominal Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrence (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['AB-1015'], 'description': 'autologous T cell therapy', 'name': 'AB-1015', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.